Key result
Intracerebroventricular clonidine lowers MAP by ~22 mm Hg via nitric oxide release.
Why the study?
The study was designed to determine whether the hypotensive action of clonidine results from its stimulation of excess nitric oxide in the brain.
Does clonidine's central hypotensive action require nitric oxide production in the brain in rat models?
Does clonidine's central hypotensive action require nitric oxide production in the brain in rat models?
Clonidine's central antihypertensive effect is mediated by the stimulation of nitric oxide release in the brain.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for NO mediation of clonidine's central action in rats; extends preclinical mechanisms but should not change practice.
Background- Clonidine has an antihypertensive effect by its action in the brain and, because we observed that the tonic production of nitric oxide (NO) in the brain is required to maintain blood pressure at its low, normotensive level, the current study was designed to determine whether the hypotensive action of clonidine resulted from its stimulation of excess NO in the brain. Methods and Results- Porphyritic microsensors were used to quantify NO concentration in the nucleus tractus solitarius (NTS) in vitro in brain slices and in vivo in the anesthetized rat. In both preparations, the basal production of NO in the NTS was 15+/-3 nmol/L. In vitro stimulation of the NTS with clonidine (50 nmol/L) resulted in an increase in the NO concentration to 84+/-7 nmol/L. In vivo, the intracerebroventricular (ICV) infusion of clonidine (0.03 microgram) caused an increase in NO concentration in the NTS to 128+/-17 nmol/L. This ICV injection of clonidine caused a fall in mean arterial pressure of -22+/-1 mm Hg and a decrease of heart rate of -18+/-2%. The blockade of NO production with N(G)-nitro-L-arginine-methyl ester (2 micromol; delivered ICV, 30 minutes before the clonidine) reduced responses to clonidine for both mean arterial pressure and heart rate (-3+/-1 mm Hg and -2+/-1% change, respectively). Conclusion- The stimulation of the release of NO in the brain by clonidine contributes to its central antihypertensive action.
No takes yet. Share an insight, caveat, or question.
Dobrucki et al. (2001) studied this question. Clonidine vs. Basal state / NO blockade with L-NAME was evaluated on Nitric oxide concentration in the nucleus tractus solitarius, mean arterial pressure, and heart rate. Intracerebroventricular infusion of clonidine increased NO concentration in the nucleus tractus solitarius and decreased mean arterial pressure by 22 mm Hg, an effect reduced by NO blockade.
Synapse has enriched 10 related papers. Consider them for comparative context: